Monique C.A. Duyndam

Author

Also Known As

M C A Duyndam, M C Duyndam, M. Duyndam, Monique C A Duyndam, Monique C. A. Duyndam, Monique C.A. Duyndam, Monique CA Duyndam, Monique Duyndam

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Amsterdam Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Monique C.A. Duyndam is an author at Vrije Universiteit Amsterdam specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	643
2	Cell Biology	5	5	564
3	Molecular Biology	3	3	431
4	Natural Sciences	2	2	52
5	Obstetrics	1	1	79

Monique C.A. Duyndam

Publications

Citations

H-Index

Page 1

	Year	Citations
Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. Hans van Dam, Monique C.A. Duyndam, Robbert J. Rottier, The EMBO Journal Molecular PhysiologySignal TransductionHeterodimer FormationMolecular VirologyPathogenesis	1993	379
Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1α Protein by the Oxidative Stressor Arsenite Monique C.A. Duyndam, T.M. Hulscher, Dennis Fontijn, Journal of Biological Chemistry	2001	116
Evidence for a Role of p38 Kinase in Hypoxia-inducible Factor 1-independent Induction of Vascular Endothelial Growth Factor Expression by Sodium Arsenite Monique C.A. Duyndam, Saskia Hulscher, Elsken van der Wall, Journal of Biological Chemistry	2003	80
Vascular Endothelial Growth Factor-165 Overexpression Stimulates Angiogenesis and Induces Cyst Formation and Macrophage Infiltration in Human Ovarian Cancer Xenografts Monique C.A. Duyndam, Marion C.G.W. Hilhorst, Hennie M.M. Schlüper, American Journal Of Pathology AngiogenesisMedicineGynecologyVascular BiologyMacrophage Infiltration	2002	79
Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells Monique C.A. Duyndam, Maria P.A. van Berkel, Josephine C. Dorsman, Biochemical Pharmacology OncologyMedicineCancer GrowthPathologyCancer Treatment	2007	76
Variation in the kinetics of caspase-3 activation, Bcl-2 phosphorylation and apoptotic morphology in unselected human ovarian cancer cell lines as a response to docetaxel Geertruida M. Kolfschoten, Theresia M. Hulscher, Monique C.A. Duyndam, Biochemical Pharmacology Apoptotic MorphologyMedicineApoptosisCell DeathPathology	2002	57
Antigenic variation in<i>Trypanosoma brucei</i>: a telomeric expression site for variant-specific surface glycoprotein genes with novel features Joost C.B.M. Zomerdijk, Rudo Kieft, Monique C.A. Duyndam, Nucleic Acids Research	1991	55
Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts Yvette van Hensbergen, Henk J. Broxterman, Sareena Rana, Clinical Cancer Research	2004	49
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells Dennis Fontijn, Monique C.A. Duyndam, Maria P.A. van Berkel, British Journal of Cancer	2006	39
The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A Monique C.A. Duyndam, Hans van Dam, Paul H.M. Smits, Oncogene Signal TransductionN-terminal Transactivation DomainCo-operative ActivationSignaling PathwayC-jun Promoter	1999	33

Page 1